Posts

Showing posts from December, 2022

HIV treatment recommendations 2022

  The International Antiviral Society-USA Panel issued their 2022 recommendations on antiretroviral drugs for treatment and prevention of HIV infections in adults ( see  hiv antiretrov recs 2022  in dropbox, or  doi:10.1001/jama.2022.22246).    Details of recommendations , along with commentary embedded in brackets    Initiation of antiretroviral therapy (ART)  -- Treat early and aggressively, preferably within seven days of diagnosis, but including the option of same-day initiation of ART on the day of diagnosis or the first clinic visit (though this assumes that there is no evidence of an opportunistic infection, which might delay starting the ART (see their Box 1 for more details on this)  -- Early therapy initiation is beneficial for a few reasons:      -- starting therapy early leads to a higher likelihood that patients will get into therapy. [This is similar to starting statins in hospitalized patients who have ...